SCHEMBL467163

SCHEMBL467163

OC(CN1CCC(Cc2ccc(F)cc2)CC1)c1sccc1Cl

nearest known ligand 0.65

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GRIN2B Q13224 2/20 0.65
GMNN O75496 1/20 0.65
TP53 P04637 1/20 0.65
CYP3A4 P08684 1/20 0.65
ALOX15 P16050 1/20 0.65
TSHR P16473 1/20 0.65
NFKB1 P19838 1/20 0.65
THPO P40225 1/20 0.65
MTOR P42345 1/20 0.65
BLM P54132 1/20 0.65
GRIN1 Q05586 1/20 0.65
NPSR1 Q6W5P4 1/20 0.65
CCR3 P51677 3/20 0.48
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
ATM Q13315 1/20 0.48
DRD4 P21917 1/20 0.46
STAT3 P40763 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Eliprodil SCHEMBL154047 0.79 GMNN (1.00) GRIN2BGMNNTP53CYP3A4ALOX15
Eliprodil SCHEMBL6254237 0.79 GMNN (1.00) GRIN2BGMNNTP53CYP3A4ALOX15
Eliprodil SCHEMBL7517402 0.79 GMNN (1.00) GRIN2BGMNNTP53CYP3A4ALOX15
Eliprodil SCHEMBL7521721 0.78 GMNN (0.98) GRIN2BGMNNTP53CYP3A4ALOX15
Eliprodil SCHEMBL7525726 0.78 GMNN (0.98) GRIN2BGMNNTP53CYP3A4ALOX15
Eliprodil SCHEMBL7212849 0.78 GMNN (0.98) GRIN2BGMNNTP53CYP3A4ALOX15
SCHEMBL467199 0.76 GRIN2B (0.73) GRIN2BGMNNTP53CYP3A4ALOX15
SCHEMBL6990168 0.75 GRIN1 (0.65) GRIN2BGMNNTP53CYP3A4ALOX15
SCHEMBL6994959 0.73 GRIN2B (0.62) GRIN2BGMNNTP53CYP3A4ALOX15
Hydrochloric Acid SCHEMBL7037163 0.72 GRIN2B (0.60) GRIN2BGMNNTP53CYP3A4ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2600863-B1 USE OF SIGMA LIGANDS IN OPIOID-INDUCED HYPERALGESIA ESTEVE LABOR DR (ES) 2018-03-28 EP disclosed
EP-2646025-B1 USE OF SIGMA LIGANDS IN BONE CANCER PAIN ESTEVE LABOR DR (ES) 2017-03-15 EP disclosed
EP-2531191-B1 Sigma ligands for use in the prevention and/or treatment of postoperative pain ESTEVE LABOR DR (ES) 2016-03-30 EP disclosed
EP-2571501-B1 SIGMA LIGANDS FOR THE PREVENTION AND/OR TREATMENT OF EMESIS INDUCED BY CHEMOTHERAPY OR RADIOTHERAPY ESTEVE LABOR DR (ES) 2016-03-02 EP disclosed
EP-2460519-A1 Use of sigma ligands in bone cancer pain Laboratorios Del. Dr. Esteve, S.A. (ES) 2012-06-06 EP disclosed
EP-2415471-A1 Use of sigma ligands in opioid-induced hyperalgesia Laboratorios Del. Dr. Esteve, S.A. (ES) 2012-02-08 EP disclosed
EP-2388005-A1 Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy Laboratorios Del. Dr. Esteve, S.A. (ES) 2011-11-23 EP disclosed
EP-2353598-A1 Sigma ligands for use in the prevention and/or treatment of postoperative pain Laboratorios Del. Dr. Esteve, S.A. (ES) 2011-08-10 EP disclosed